Evidence map›Paper›PMID 38229336›Full record

ArticleBalkan medical journal2024

Xin Jin, Qing Hu, Meiying Qin, Yitong Yin, Zhijun Xia

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Balkan medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Research progress of stem cells in the treatment of atherosclerosis.Frontiers in cell and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xin JinDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, ChinaORCID 0009-0000-8599-9033
Qing HuDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, ChinaORCID 0009-0001-8022-763X
Meiying QinDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, ChinaORCID 0000-0001-6493-7976
Yitong YinDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, ChinaORCID 0009-0008-7283-5820
Zhijun XiaDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, ChinaORCID 0009-0007-4352-6693
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pelvic organ prolapse (POP) is a common gynecological chronic disorder. Human vaginal fibroblasts (HVFs) that maintain the integrity of vaginal wall tissues are essential for keeping pelvic organs in place. Apoptosis and the degradation of the extracellular matrix in HVFs contribute to the progression of POP. The cytokine signal transduction inhibitor 3 ( Aims: To explore the role and mechanism of Study Design: In vitro cell lines and human-sample study. Methods: Anterior vaginal wall tissues were obtained from POP or non-POP patients for the analysis of Results: Conclusion:

Indexed as

Pelvic Organ ProlapseApoptosisCollagenExtracellular MatrixFemaleFibroblastsHumansNuclear Receptor Subfamily 4, Group A, Member 1Suppressor of Cytokine Signaling 3 ProteinCollagenNR4A1 protein, humanNuclear Receptor Subfamily 4, Group A, Member 1SOCS3 protein, humanSuppressor of Cytokine Signaling 3 Protein

Identifiers

PMID38229336
PMCPMC10913121
OpenAlexW4390953981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.